Cited by 38

Association between serum per- and polyfluoroalkyl substances concentrations and common cold among children and adolescents in the United States

Zhang, Yu, Mustieles, Vicente, Sun, Yang, Oulhote, Youssef, Wang, Yi-Xin, Messerlian, Carmen·2022·Environment International

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.envint.2022.107239

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Ait Bamai Y.u., Goudarzi H, Araki A, Okada E, Kashino I, Miyashita C, Kishi R, 2020. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The hokkaido study on environment and children’s health. Environ. Int. 143. 32717646
  2. Bennett DH, Calafat AM, Kato K, Strynar M, Andersen E, Moran RE,, 2015. Serum concentrations of perfluorinated compounds (pfc) among selected populations of children and adults in California. Environmental research 136, 264– 273. 25460645 PMC4724210
  3. Bjerregaard-Olesen C, Bach CC, Long M, Ghisari M, Bossi R, Bech BH, Nohr EA, Henriksen TB, Olsen J, Bonefeld-Jørgensen EC, 2016. Time trends of perfluorinated alkyl acids in serum from danish pregnant women 2008–2013. Environ. Int. 91, 14– 21. 26891270
  4. Bobb JF, Valeri L, Claus Henn B, Christiani DC, Wright RO, Mazumdar M, Godleski JJ, Coull BA, 2015. Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures. Biostatistics 16 (3), 493– 508. 25532525 PMC5963470
  5. Buck RC, Franklin J, Berger U, Conder JM, Cousins IT, de Voogt P, Jensen AA, Kannan K, Mabury SA, van Leeuwen SPJ, 2011. Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and origins. Integr. Environ. Assess. Manage. 7 (4), 513– 541. PMC3214619 21793199
  6. Bulka CM, Avula V, Fry RC, 2021. Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: Recent findings from nhanes 1999–2016. Environ. Pollut. 275. PMC7957906 33578314
  7. Calafat AM, Kato K, Hubbard K, Jia T, Botelho JC, Wong L-Y, 2019. Legacy and alternative per- and polyfluoroalkyl substances in the u.S. Environ. Int. 131, 105048. PMC7879379 31376596
  8. Chen T-C, Parker JD, Clark J, Shin H-C, Rammon JR, Burt VL, 2018. National health and nutrition examination survey: Estimation procedures, 2011–2014. 29775431
  9. Christofides A, Konstantinidou E, Jani C, Boussiotis VA, 2021. The role of peroxisome proliferator-activated receptors (ppar) in immune responses. Metabolism 114. PMC7736084 32791172
  10. Conder JM, Hoke RA, Wolf W.d., Russell MH, Buck RC, 2008. Are pfcas bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ. Sci. Technol. 42 (4), 995– 1003. 18351063
  11. Corsini E, Luebke RW, Germolec DR, DeWitt JC, 2014. Perfluorinated compounds: Emerging pops with potential immunotoxicity. Toxicol. Lett. 230 (2), 263– 270. 24503008 PMC4439925
  12. Dalsager L, Christensen N, Husby S, Kyhl H, Nielsen F, Høst A, Grandjean P, Jensen TK, 2016. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1–4years among 359 children in the odense child cohort. Environ. Int. 96, 58– 64. 27608427
  13. Dalsager L, Christensen N, Halekoh U, Timmermann CAG, Nielsen F, Kyhl HB,, 2021. Exposure to perfluoroalkyl substances during fetal life and hospitalization for infectious disease in childhood: A study among 1,503 children from the odense child cohort. Environ. Int. 149, 106395. 33508532
  14. Daly ER, Chan BP, Talbot EA, Nassif J, Bean C, Cavallo SJ, Metcalf E, Simone K, Woolf AD, 2018. Per-and polyfluoroalkyl substance (pfas) exposure assessment in a community exposed to contaminated drinking water, new hampshire, 2015. Int. J. Hyg. Environ. Health 221 (3), 569– 577. 29514764
  15. Ding N, Harlow SD, Batterman S, Mukherjee B, Park SK, 2020. Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: The study of women’s health across the nation. Environ. Int. 135. PMC7374929 31841808
  16. Eriksson U, Mueller JF, Toms L-M-L, Hobson P, Kärrman A, 2017. Temporal trends of pfsas, pfcas and selected precursors in australian serum from 2002 to 2013. Environ. Pollut. 220, 168– 177. 27726977
  17. Fei C, McLaughlin JK, Lipworth L, Olsen J, 2010. Prenatal exposure to pfoa and pfos and risk of hospitalization for infectious diseases in early childhood. Environ. Res. 110 (8), 773– 777. 20800832
  18. Fenton SE, Ducatman A, Boobis A, DeWitt JC, Lau C, Ng C, Smith JS, Roberts SM, 2020. Per-and polyfluoroalkyl substance toxicity and human health review: Current state of knowledge and strategies for informing future research. Environ. Toxicol. Chem. 40 (3), 606– 630. 33017053 PMC7906952
  19. Georgountzou A, Papadopoulos NG, 2017. Postnatal innate immune development: From birth to adulthood. Front. Immunol. 8. PMC5554489 28848557
  20. Goudarzi H, Miyashita C, Okada E, Kashino I, Chen C-J, Ito S, Araki A, Kobayashi S, Matsuura H, Kishi R, 2017. Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4 years of age. Environ. Int. 104, 132– 138. 28392064
  21. Grandjean P, 2018. Delayed discovery, dissemination, and decisions on intervention in environmental health: a case study on immunotoxicity of perfluorinated alkylate substances. Environ Health 17 (1). PMC6066926 30060739
  22. Granum B, Haug LS, Namork E, Stølevik SB, Thomsen C, Aaberge IS, van Loveren H, Løvik M, Nygaard UC, 2013. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J. Immunotoxicol. 10 (4), 373– 379. 23350954
  23. Hansen KJ, Clemen LA, Ellefson ME, Johnson HO, 2001. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35 (4), 766– 770. 11349290
  24. Harris MH, Rifas-Shiman SL, Calafat AM, Ye X, Mora AM, Webster TF, Oken E, Sagiv SK, 2017. Predictors of per-and polyfluoroalkyl substance (pfas) plasma concentrations in 6–10 year old american children. Environ. Sci. Technol. 51 (9), 5193– 5204. 28325044 PMC5576362
  25. Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO, 2010. Allergic rhinitis and the common cold–high cost to society. Allergy 65, 776– 783. 19958315
  26. Hornung RW, Reed LD, 1990. Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hyg. 5 (1), 46– 51.
  27. Huang H, Yu K, Zeng X, Chen Q, Liu Q, Zhao Y, Zhang J, Zhang X.i., Huang L, 2020. Association between prenatal exposure to perfluoroalkyl substances and respiratory tract infections in preschool children. Environ. Res. 191. 32871147
  28. Hurley S, Goldberg D, Wang M, Park J-S, Petreas M, Bernstein L, Anton-Culver H, Nelson DO, Reynolds P, 2018. Time trends in per-and polyfluoroalkyl substances (pfass) in california women: Declining serum levels, 2011–2015. Environ. Sci. Technol. 52 (1), 277– 287. 29198103
  29. Impinen A, Nygaard UC, Lødrup Carlsen KC, Mowinckel P, Carlsen KH, Haug LS, Granum B, 2018. Prenatal exposure to perfluoralkyl substances (pfass) associated with respiratory tract infections but not allergy-and asthma-related health outcomes in childhood. Environ. Res. 160, 518– 523. 29106950
  30. Impinen A, Longnecker MP, Nygaard UC, London SJ, Ferguson KK, Haug LS, Granum B, 2019. Maternal levels of perfluoroalkyl substances (pfass) during pregnancy and childhood allergy and asthma related outcomes and infections in the norwegian mother and child (moba) cohort. Environ. Int. 124, 462– 472. 30684804 PMC8261530
  31. Jayes L, Haslam PL, Gratziou CG, Powell P, Britton J, Vardavas C, Jimenez-Ruiz C, Leonardi-Bee J.o., Dautzenberg B, Lundbäck B.o., Fletcher M, Turnbull A, Katsaounou P, Heederik D, Smyth D, Ravara S, Sculier J-P, Martin F, De Grada Orive JI, 2016. Smokehaz: Systematic reviews and meta-analyses of the effects of smoking on respiratory health. Chest 150 (1), 164– 179. 27102185
  32. Khazaee M, Christie E, Cheng W, Michalsen M, Field J, Ng C, 2021. Perfluoroalkyl acid binding with peroxisome proliferator-activated receptors α, γ, and δ, and fatty acid binding proteins by equilibrium dialysis with a comparison of methods. Toxics 9. PMC7996760 33652875
  33. Kim S, 2016. Overview of cotinine cutoff values for smoking status classification. Int. J. Environ. Res. Public Health 13 (12), 1236. 27983665 PMC5201377
  34. Kingsley SL, Eliot MN, Kelsey KT, Calafat AM, Ehrlich S, Lanphear BP, Chen A, Braun JM, 2018. Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood. Environ. Res. 165, 247– 257. 29734025 PMC6309672
  35. Koponen J, Winkens K, Airaksinen R, Berger U, Vestergren R, Cousins IT, Karvonen AM, Pekkanen J, Kiviranta H, 2018. Longitudinal trends of per- and polyfluoroalkyl substances in children’s serum. Environ. Int. 121, 591– 599. 30308470
  36. Kotthoff M, Müller J, Jürling H, Schlummer M, Fiedler D, 2015. Perfluoroalkyl and polyfluoroalkyl substances in consumer products. Environ. Sci. Pollut. Res. 22 (19), 14546– 14559. PMC4592498 25854201
  37. Laffont S, Guéry JC, 2019. Deconstructing the sex bias in allergy and autoimmunity: From sex hormones and beyond. Adv. Immunol. 142, 35– 64. 31296302
  38. Liew Z, Goudarzi H, Oulhote Y, 2018. Developmental exposures to perfluoroalkyl substances (pfass): An update of associated health outcomes. Curr Environ Health Rep 5 (1), 1– 19. 29556975 PMC6348874
  39. Mannino DM, Moorman JE, Kingsley B, Rose D, Repace J, 2001. Health effects related to environmental tobacco smoke exposure in children in the united states: Data from the third national health and nutrition examination survey. Arch. Pediatr. Adolesc. Med. 155, 36– 41. 11177060
  40. Manzano-Salgado CB, Granum B, Lopez-Espinosa M-J, Ballester F, Iñiguez C, Gascón M, Martínez D, Guxens M, Basterretxea M, Zabaleta C, Schettgen T, Sunyer J, Vrijheid M, Casas M, 2019. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a spanish birth cohort study. Int. J. Hyg. Environ. Health 222 (6), 945– 954. 31262703
  41. Mondal D, Lopez-Espinosa M-J, Armstrong B, Stein CR, Fletcher T, 2012. Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother–child pairs in a population with perfluorooctanoate exposure from drinking water. Environ. Health Perspect. 120 (5), 752– 757. 22271837 PMC3346790
  42. Moore SE, Collinson AC, Tamba N’Gom P.a., Aspinall R, Prentice AM, 2006. Early immunological development and mortality from infectious disease in later life. Proc. Nutr. Soc. 65 (3), 311– 318. 16923314
  43. Nyström J, Benskin JP, Plassmann M, Sandblom O, Glynn A, Lampa E,, 2022. Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (pfas) concentrations in a national cross-sectional survey of swedish adolescents. Environ. Res. 208, 112674. 34998808
  44. Okada E, Sasaki S, Saijo Y, Washino N, Miyashita C, Kobayashi S, Konishi K, Ito YM, Ito R, Nakata A, Iwasaki Y, Saito K, Nakazawa H, Kishi R, 2012. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants. Environ. Res. 112, 118– 125. 22030285
  45. Oulhote Y, Shamim Z, Kielsen K, Weihe P, Grandjean P, Ryder LP, Heilmann C, 2017. Children’s white blood cell counts in relation to developmental exposures to methylmercury and persistent organic pollutants. Reprod. Toxicol. 68, 207– 214. 27497749 PMC5292093
  46. Pennings JLA, Jennen DGJ, Nygaard UC, Namork E, Haug LS, van Loveren H, Granum B, 2016. Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood. J Immunotoxicol 13 (2), 173– 180. 25812627
  47. Polyzoi E, Polyzois D, 2017. Presence of household mold, children’s respiratory health, and school absenteeism: Cause for concern. J. Environ. Health 79, 28– 35. 29144078
  48. Rappazzo KM, Coffman E, Hines EP, 2017. Exposure to perfluorinated alkyl substances and health outcomes in children: A systematic review of the epidemiologic literature. Int. J. Environ. Res. Public Health 14, 691. 28654008 PMC5551129
  49. Schrenk D, Bignami M, Bodin L, Chipman JK, del Mazo J, Grasl-Kraupp B, Hogstrand C, Hoogenboom L(., Leblanc J-C, Nebbia CS, Nielsen E, Ntzani E, Petersen A, Sand S, Vleminckx C, Wallace H, Barregård L, Ceccatelli S, Cravedi J-P, Halldorsson TI, Haug LS, Johansson N, Knutsen HK, Rose M, Roudot A-C, Van Loveren H, Vollmer G, Mackay K, Riolo F, Schwerdtle T, 2020. Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA J. 18 (9), e06223. PMC7507523 32994824
  50. Sunderland EM, Hu XC, Dassuncao C, Tokranov AK, Wagner CC, Allen JG, 2019. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (pfass) and present understanding of health effects. J. Eposure Sci. Environ. Epidemiol. 29 (2), 131– 147. PMC6380916 30470793
  51. Timmermann CAG, Jensen KJ, Nielsen F, Budtz-Jørgensen E, van der Klis F, Benn CS,, 2020. Serum perfluoroalkyl substances, vaccine responses, and morbidity in a cohort of guinea-bissau children. Environ. Health Perspect. 128, 087002. PMC7416537 32772733
  52. Wang Z, Shi R, Ding G, Yao Q, Pan C, Gao Y.u., Tian Y, 2022. Association between maternal serum concentration of perfluoroalkyl substances (pfass) at delivery and acute infectious diseases in infancy. Chemosphere 289. 34896425
  53. Weisskopf MG, Seals RM, Webster TF, 2018. Bias amplification in epidemiologic analysis of exposure to mixtures. Environ. Health Perspect. 126 (4). PMC6071813 29624292
  54. Ye X, Kato K, Wong L-Y, Jia T, Kalathil A, Latremouille J, Calafat AM, 2018. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the national health and nutrition examination survey 2013–2014. Int. J. Hyg. Environ. Health 221 (1), 9– 16. 28993126 PMC5726901
  55. Zazara DE, Arck PC, 2019. Developmental origin and sex-specific risk for infections and immune diseases later in life. Semin. Immunopathol. 41 (2), 137– 151. 30298432

Cited by

Sorted by citations

Authors
Zhang, Y., Mustieles, V., Sun, Y., Oulhote, Y., Wang, Y.-X., & Messerlian, C.
Venue
Environment International
Publisher
Elsevier BV
Published
2022-06
Volume
164
Pages
107239
ISSN
0160-4120
Cited by
38
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review